Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemischer Name: H-D-Phe-Cys-Tyr-D-Trp-Lys(ICG)-Cys-Thr-NH2 (disulfide bridged) // Synonyme: CAP-232-ICG, TLN-232-ICG, TT232-ICG, TT 232-ICG, TT-232-ICG
Ab 756,00 €
TT-232 is a structural analogue of somatostatin, a hormone with significant, selective antiproliferative, anti-inflammatory and antisecretory properties. In contrast to the parent hormone and its “traditional” analogues, this compound has strong and specific growth-inhibitory potential without the wide-ranging endocrine side-effects, including inhibition of insulin secretion provoking diabetes. Its mechanism of action is in line with the so-called signal-transduction therapy, where "internal communication" of cells is corrected without interfering with basic cell functions and machinery. Moreover, TT-232 acts on pyruvate kinase translocation and neurogenic inflammation. In vitro and in vivo studies show a selective antitumor activity with induction of strong apoptosis of cancer cells.
Indocyanine green (ICG) is a near-infrared fluorescence imaging dye. Absorption maximum is at 800 nm and there is slight absorption in the visible range, which results in low auto-fluorescence and tissue absorbance. Emission maximum is at 810 nm. ICG has been approved by the FDA.
Evaluation of the Antitumor Efficacy of the Somatostatin Structural Derivative TT-232 on Different Tumor Models; M. Tejeda, D. Gaál, L. Hullán, B. Hegymegi-Barakonyi, G. Kéri; Anticancer Res. 2006; 26: 3477-83.
A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity; G. Kéri, J. Erchegyi, A. Horváth, I. Mezõ, M. Idei, T. Vántus, A. Balogh, Z. Vadász, G. Bökönyi, J. Seprõdi, I. Teplán, O. Csuka, M. Tejeda, D. Gaál, Z. Szegedi, B. Szende, C. Roze, H. Kalthoff, A. Ullrich; Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 12513-12518. https://doi.org/10.1073/pnas.93.22.12513
Inhibitory Effects of Synthetic Somatostatin Receptor Subtype 4 Agonists on Acute and Chronic Airway Inflammation and Hyperreactivity in the Mouse; K. Elekes, Z. Helyes, L. Kereskai, K. Sándor, E. Pintér, G. Pozsgai, V. Tékus, A. Bánvölgyi, J. Németh, T. Szuts, G. Kéri, J. Szolcsányi; Eur. J. Pharmacol. 2008; 578: 313-22. https://doi.org/10.1016/j.ejphar.2007.09.033
Inhibitory Effect of Peptide Mimetics Including Naphthyl Group on DNA Polymerase b Activity; A. Miyazaki, R. Ito, A. Enomoto, Y. Tsuda, I. Kuriyama, H. Yoshida, Y. Mizushina; Peptide Science 2013; 49: 201-202.
Somatostatin stimulates the migration of hepatic oval cells in the injured rat liver; Y. Jung, S.-H. Oh, R. P. Witek, B. E. Petersen; Liver International 2011; 32: 312-320. https://doi.org/10.1111/j.1478-3231.2011.02642.x